TrialImmunity, inflammation and disease2021

A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.

Uta Herden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.